What was the overall market valuation of the US valley fever market in 2024?

The overall market valuation of the US valley fever market was $288.4 Million in 2024. Read More

What is the projected market valuation for the US valley fever market by 2035?

The projected market valuation for the US valley fever market is $418.54 Million by 2035. Read More

What is the expected CAGR for the US valley fever market during the forecast period 2025 - 2035?

The expected CAGR for the US valley fever market during the forecast period 2025 - 2035 is 3.44%. Read More

Which companies are considered key players in the US valley fever market?

Key players in the US valley fever market include Astellas Pharma, Gilead Sciences, Merck & Co, Pfizer, Bristol-Myers Squibb, Amgen, Novartis, Sanofi, and Eli Lilly and Company. Read More

What are the main types of treatments available in the US valley fever market?

The main types of treatments in the US valley fever market include Fluconazole, Itraconazole, Voriconazole, Posaconazole, and others. Read More

What was the market value for Fluconazole in 2024?

The market value for Fluconazole in 2024 was between $80.0 Million and $115.0 Million. Read More

How does the market value for lung infections compare to other sites of infection?

The market value for lung infections was between $100.0 Million and $150.0 Million, making it the highest among other sites of infection. Read More

What is the market value range for treatments targeting the liver in 2024?

The market value range for treatments targeting the liver in 2024 was between $20.0 Million and $30.0 Million. Read More

What is the projected market value for cattle in the US valley fever market by 2035?

The projected market value for cattle in the US valley fever market is expected to be between $50.0 Million and $70.0 Million by 2035. Read More

What is the market value for 'Others' in the end-use segment for 2024?

The market value for 'Others' in the end-use segment was between $118.4 Million and $173.54 Million in 2024. Read More

US Valley Fever Market

ID: MRFR/Pharma/18534-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Valley Fever Market Research Report By Types of Treatments (Fluconazole, Itraconazole, Voriconazole, Posaconazole, Others) and By Site of Infection (Skin, Liver, Bones, Heart, Brain, Membranes That Surround the Brain and Spinal Cord, Others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Types of Treatments (USD Million)
  1. 4.1.1 Fluconazole
  2. 4.1.2 Itraconazole
  3. 4.1.3 Voriconazole
  4. 4.1.4 Posaconazole
  5. 4.1.5 Others
2. 4.2 Medical Device, BY Site of Infection (USD Million)
  1. 4.2.1 Skin
  2. 4.2.2 Lungs
  3. 4.2.3 Liver
  4. 4.2.4 Bones
  5. 4.2.5 Heart
  6. 4.2.6 Brain
  7. 4.2.7 Membranes that Surround the Brain and Spinal Cord
  8. 4.2.8 Others
3. 4.3 Medical Device, BY End-Use (USD Million)
  1. 4.3.1 Human
  2. 4.3.2 Cattle
  3. 4.3.3 Sheep and goats
  4. 4.3.4 Camel
  5. 4.3.5 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Astellas Pharma (JP)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Gilead Sciences (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Merck & Co (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Pfizer (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Bristol-Myers Squibb (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Amgen (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Novartis (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sanofi (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Eli Lilly and Company (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPES OF TREATMENTS
3. 6.3 US MARKET ANALYSIS BY SITE OF INFECTION
4. 6.4 US MARKET ANALYSIS BY END-USE
5. 6.5 KEY BUYING CRITERIA OF MEDICAL DEVICE
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF MEDICAL DEVICE
8. 6.8 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
9. 6.9 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
11. 6.11 MEDICAL DEVICE, BY TYPES OF TREATMENTS, 2024 (% SHARE)
12. 6.12 MEDICAL DEVICE, BY TYPES OF TREATMENTS, 2024 TO 2035 (USD Million)
13. 6.13 MEDICAL DEVICE, BY SITE OF INFECTION, 2024 (% SHARE)
14. 6.14 MEDICAL DEVICE, BY SITE OF INFECTION, 2024 TO 2035 (USD Million)
15. 6.15 MEDICAL DEVICE, BY END-USE, 2024 (% SHARE)
16. 6.16 MEDICAL DEVICE, BY END-USE, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPES OF TREATMENTS, 2025-2035 (USD Million)
  2. 7.2.2 BY SITE OF INFECTION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Types of Treatments (USD Million, 2025-2035)

Fluconazole
Itraconazole
Voriconazole
Posaconazole
Others

Medical Device By Site of Infection (USD Million, 2025-2035)

Skin
Lungs
Liver
Bones
Heart
Brain
Membranes that Surround the Brain and Spinal Cord
Others

Medical Device By End-Use (USD Million, 2025-2035)

Human
Cattle
Sheep and goats
Camel
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”